ArticleFrontiers in pharmacology2025
Anticancer ethnomedicines for cancer treatment in Taiwan.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cancer remains a leading global health issue and has been the leading cause of death in Taiwan for over four decades. In recent years, ethnomedicines have gained growing attention as complementary therapies in cancer treatment. However, systematic investigations linking traditional medicinal practices with cancer remain limited. This study aims to explore the types, preparation methods, and parts used of anticancer ethnomedicines and cancer types across different regions in Taiwan through ethnobotanical surveys, and to preserve and transmit traditional knowledge. Methods: Data were collected through questionnaire-based interviews with 210 participants, sampled proportionally by region, age, gender, and education based on national demographics. Results: Chi-squared tests showed that only education level significantly influenced the number of anticancer ethnomedicines mentioned ( Discussion: In summary, the results of this study provide a valuable foundation for future anticancer research, serving as a priority focus for further investigation into the underlying mechanisms of anticancer activity. Moreover, this research supports the scientific development and potential drug discovery of ethnomedicines in modern cancer treatment, contributing to the integration of traditional knowledge with contemporary biomedical approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.